SIRNAOMICS-B (02257) announced that Subscription Agreement B was partially completed on December 7, 2025, with the issuance of 1,003,700 new shares to Subscriber B at HK$12.00 per share. Following amicable negotiations, the company and Subscriber B mutually agreed to terminate the subscription of the remaining 2,151,300 shares on the same date. Upon termination, all rights and obligations under the agreement ceased, and neither party may claim against the other regarding Subscription Agreement B. The Board confirmed that terminating the remaining subscription will not materially adversely affect the company's existing business, operations, or financial condition.

Separately, Subscriber C failed to fulfill its obligations under Subscription Agreement C by December 7, 2025, prompting the company to terminate the agreement per its terms. Post-termination, all contractual rights and obligations were extinguished without recourse for either party. The Board stated that terminating Subscription Agreement C would not materially impact the company's current operations or financial standing.